Beckman Main Calendar

-

Thursday, March 30, 2017

Friday, March 31, 2017

Tuesday, April 4, 2017

    • 4:00 pm
    • Beckman Institute, 4th floor tower room, 4269

    Jake Berndt, "Effects of an Intervention Diet in the PATH Study" Joe Rowles, "Impact of Isolated Soy Protein in Non-Alcoholic Fatty Liver Disease Progression: Monitored by QUS"

Wednesday, April 5, 2017

Thursday, April 6, 2017

Friday, April 7, 2017

Tuesday, April 11, 2017

    • 4:00 pm
    • Beckman Institute, 4th floor tower room, 4269

    Jake Berndt, "Effects of an Intervention Diet in the PATH Study" Joe Rowles, "Impact of Isolated Soy Protein in Non-Alcoholic Fatty Liver Disease Progression: Monitored by QUS"

Friday, April 14, 2017

Tuesday, April 18, 2017

    • 4:00 pm
    • Beckman Institute, 4th floor tower room, 4269

    Jake Berndt, "Effects of an Intervention Diet in the PATH Study" Joe Rowles, "Impact of Isolated Soy Protein in Non-Alcoholic Fatty Liver Disease Progression: Monitored by QUS"

Tuesday, April 25, 2017

    • 4:00 pm
    • Beckman Institute, 4th floor tower room, 4269

    Jake Berndt, "Effects of an Intervention Diet in the PATH Study" Joe Rowles, "Impact of Isolated Soy Protein in Non-Alcoholic Fatty Liver Disease Progression: Monitored by QUS"

Tuesday, May 2, 2017

    • 4:00 pm
    • Beckman Institute, 4th floor tower room, 4269

    Jake Berndt, "Effects of an Intervention Diet in the PATH Study" Joe Rowles, "Impact of Isolated Soy Protein in Non-Alcoholic Fatty Liver Disease Progression: Monitored by QUS"

Wednesday, May 3, 2017

Tuesday, May 9, 2017

    • 4:00 pm
    • Beckman Institute, 4th floor tower room, 4269

    Jake Berndt, "Effects of an Intervention Diet in the PATH Study" Joe Rowles, "Impact of Isolated Soy Protein in Non-Alcoholic Fatty Liver Disease Progression: Monitored by QUS"

Tuesday, May 16, 2017

    • 4:00 pm
    • Beckman Institute, 4th floor tower room, 4269

    Jake Berndt, "Effects of an Intervention Diet in the PATH Study" Joe Rowles, "Impact of Isolated Soy Protein in Non-Alcoholic Fatty Liver Disease Progression: Monitored by QUS"